Press Releases
TITUSVILLE, N.J., Nov. 16, 2019 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the launch of the next evolution of digital clinical trial design with CHIEF-HF, the first-ever completely decentralized, mobile, indication-seeking clinical study. To accelerate the study and fast-track results, all
Read more...16 November 2019
THOUSAND OAKS, Calif., Nov. 16, 2019 /PRNewswire/ -- Amgen today announced a new analysis from the Repatha® (evolocumab) cardiovascular outcomes (FOURIER) study that evaluates the effectiveness of Repatha in patients who have suffered a recent myocardial infarction (MI). The analysis showed that patients who experienced a recent MI (less than one year
Read more...IRVING, Texas, Nov. 15, 2019 /PRNewswire/ -- Choice Cancer Care Treatment Center ("Choice Cancer Care") operates cancer treatment centers in Texas where it offers individualized cancer treatment plans for patients. Choice Cancer Care is providing notice of an incident that may have involved the privacy of certain patie
Read more...15 November 2019
NEW YORK, Nov. 15, 2019 /PRNewswire/ -- Below are experts from the ProfNet network who are available to discuss timely issues in your coverage area.
Read more...SILVER SPRING, Md., Nov. 15, 2019 /PRNewswire/ -- Biological products play an increasingly central role in modern medicine, offering treatments for many serious illnesses. Commonly referred to as biologics, these medicines are generally made from natural or living sources, like animal and plant cells, and microorganisms such as bacteria or yeast, and developed using adva
Read more...15 November 2019
AUSTIN, Texas, Nov. 15, 2019 /PRNewswire/ -- VA2CS, the European leader in AI-Powered Fall Detection and Prevention, is launching its product at GSA 2019! The solution is already deployed in 2
Read more...15 November 2019
BAKERSFIELD, Calif., Nov. 15, 2019 /PRNewswire/ -- On Tuesday, November 19, 2019, Healthcare Trust of America, Inc. will officially commence construction on a new 90,000 square foot state-of-the-art healthcare center and medical office building. The 3-story structure will be located across the street from Bakersfield Memori
Read more...15 November 2019
SILVER SPRING, Md., Nov. 15, 2019 /PRNewswire/ -- The U.S. Food and Drug Administration today approved the first contact lens indicated to slow the progression of myopia (nearsightedness) in children between the ages of 8 and 12 years old at the initiation of treatment. The MiSight contact lens is a single use, disposable, soft contact lens that is discarded at the
Read more...